FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

eSubmission Template for Device De Novo Filings

Federal Register notice: FDA makes available a final guidance entitled Electronic Submission Template for Medical Device De Novo Requests.

latest-news-card-1
Federal Register

ANDA Product-Specific Guidances Available

Federal Register notice: FDA is making available additional draft and revised draft product-specific guidances that provide recommendations on, among ...

latest-news-card-1
Human Drugs

SurGenTech Bone Marrow Aspirate Kit Cleared

FDA clears a SurGenTec 510(k) for its proprietary B-MAN Bone Marrow Aspirate Kit.

latest-news-card-1
Medical Devices

Class 1 Recall of ClotTriever XL

Inari Medical begins a Class 1 recall to update the use instructions for its ClotTriever XL catheter after discovering serious adverse events caused w...

latest-news-card-1
Medical Devices

De Novo Electronic Submission Template

FDA publishes a guidance to help submitters of de novo requests use an electronic format template.

latest-news-card-1
Medical Devices

Request for Information Guidance

FDA publishes a guidance on procedures for submitting section 513(g) requests for information on medical device classification.

latest-news-card-1
Human Drugs

Liquidia Sues FDA Over Tyvasos Exclusivity

Liquidia Corp. sues FDA over the agencys recent decision to grant United Therapeutics Corp. an additional three-year exclusivity period for Tyvaso DPI...

Medical Devices

FDA Clears Hydros Robotic System

FDA clears Procept BioRobotics Hydros Robotic System used for aquablation therapy in patients with benign prostatic hyperplasia.

latest-news-card-1
Human Drugs

Bumpus Refuses to Approve Intarcia NDA

FDA principal deputy commissioner Namandj Bumpus says CDER correctly denied approval of a 2016 Intarcia NDA for ITCA 650 to treat Type 2 diabetes.

latest-news-card-1
Federal Register

Panel to Mull Stomach/Esophagus Cancer Therapies

Federal Register notice: FDA announces a 9/26 Oncologic Drugs Advisory Committee meeting to discuss the use of immune checkpoint inhibitors in patient...